Theodore Cooper Memorial Lecture. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease.
about
Kallistatin is a potent new vasodilatorHuman kininogen gene is transactivated by the farnesoid X receptorIn vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensingOntogenetic aspects of hypertension development: analysis in the rat.Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase.In vivo bradykinin B2 receptor activation reduces renal fibrosis.The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive ratsThe renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension.Novel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator.Therapeutic potential of angiotensin receptor blockers in hypertension.Human plasma protein N-glycosylationKininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study.The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development ConceptTissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5.Protease-activated receptors in kidney disease progression.3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression.Isolation and biochemical characterization of bradykinin-potentiating peptides from Bitis gabonica rhinoceros.Messages from an isolate: lessons from the Finnish gene pool.Analysis of population-specific pharmacogenomic variants using next-generation sequencing data.Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.Intramuscular delivery of rAAV-mediated kallikrein gene reduces hypertension and prevents cardiovascular injuries in model rats.Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients.Contraction-related factors affect the concentration of a kallidin-like peptide in rat muscle tissue.Angiotensin II clamp prevents the second step in renal apical NHE3 internalization during acute hypertension.Mechanisms of angiotensin II-induced expression of B2 kinin receptors.Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries.Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans.Circulating kallikreins during sodium chloride infusion in normal and hypertensive humans.17Beta-oestradiol enhances the acute hypotensive effect of captopril in female ovariectomized spontaneously hypertensive rats.Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE/NEP inhibitors GW660511X and omapatrilat
P2860
Q24561603-4B440AAF-B64E-46E3-BF39-D9F6B37F2899Q28205786-1870C27B-A330-4D1E-9C5C-6DA9AACEBD97Q28542384-695C1950-42E9-4F69-AAD9-4DB75EE9D0DFQ33744642-B6404F17-DD42-4313-8D7E-64F247BC7717Q33784439-32395C45-17E4-43A9-ADEB-88D0A4AE50B8Q34795075-97B07ED6-CD2F-4410-B703-44CF4059C8BDQ35028743-A8B6CF38-08A5-4FBB-9DE2-BA8538F79AF9Q35081897-037E724C-AC0C-4C9D-B8BC-1D83FFA0DC62Q35112051-0DE243F5-6FF3-4985-9AA9-5C573C8313AEQ36491825-CDD25581-6810-4F01-BCCF-2B2AFCC1A903Q36963945-DC503258-500A-4FA6-AA8C-5D09D0573B76Q37354446-BE4920F2-7215-406E-BCA1-03AAF30A3E36Q37381826-D50F8803-92DD-48AD-B30F-A5F68AA2EF56Q37709440-A30AAD8E-B44B-404B-9E6D-BA96950D076AQ38774298-3D2E36E4-C56E-404D-8C36-1A5F6FD86BFBQ38979080-034BF1F9-19C7-4717-A60F-E69383EC59F6Q40376651-C70D48D0-2A6E-4228-903E-C498D703854BQ41036113-605665B2-954B-437F-8F37-06A7B1CE09F6Q41386249-62E78BB7-ABB8-4CEA-A942-915226A6AA07Q41606948-9F5F77BB-AE7B-4A77-B99B-51C1594BAD4CQ42669799-A5046F6B-8831-4D4D-9E5C-3A7B6F04B9D0Q43776054-535DD2D5-6FE8-4497-9543-BF9F62937BA3Q44003398-D54E600E-67F9-4FC0-8FD5-98C981D73B49Q44161136-C7697AAB-3727-4F1F-906C-ABAABADB29EDQ44174268-92E5578F-F09A-430A-9670-3E352A89F566Q44758286-FCBB5CD1-2D69-4844-B585-DB7F0D5CD78BQ45631931-ABBF3A7D-FA79-4680-94AB-EB9400CBD839Q46477408-AFDBB13A-C1EF-4E53-A4B5-EC245BB69B8AQ50951974-CF284EB2-F2E5-4107-AE88-E956E1A7D673Q51809464-1A5A5CB6-6DB9-47AC-8D35-81B6EB0D6372Q57101724-D98F27E2-712B-415A-9445-8219A67B5F79
P2860
Theodore Cooper Memorial Lecture. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Theodore Cooper Memorial Lectu ...... cs and roles in human disease.
@en
type
label
Theodore Cooper Memorial Lectu ...... cs and roles in human disease.
@en
prefLabel
Theodore Cooper Memorial Lectu ...... cs and roles in human disease.
@en
P356
P1433
P1476
Theodore Cooper Memorial Lectu ...... cs and roles in human disease.
@en
P2093
H S Margolius
P304
P356
10.1161/01.HYP.26.2.221
P407
P577
1995-08-01T00:00:00Z